San Francisco-based AliveCor has received FDA clearance for two new algorithms for its smartphone-connected ECG: one that detects normality and one that detects interference. These follow up on ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leading AI-driven health technology company and portfolio company of nference, announced today it has received the 2024 MedTech Breakthrough Award ...
DiaCardia, a novel artificial intelligence model that can accurately identify individuals with prediabetes using either ...
Please provide your email address to receive an email when new articles are posted on . Algorithms to improve ECG interpretability received FDA clearance. The solution is designed to reduce noise ...
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), an artificial intelligence (AI)-powered ...
(RTTNews) - HeartSciences (HSCS, HSCSW) announced that the FDA has granted Breakthrough Device designation for its Aortic Stenosis ECG algorithm. The algorithm would offer a AI-driven ECG solution ...
While AliveCore faced two wins, the dispute did not end there. In March 2025, Apple triumphed in a major patent dispute with ...
BELFAST, Northern Ireland, May 19, 2023 /PRNewswire/ -- PulseAI, a leader in the development of cutting-edge AI-powered ECG software, has released the results of a clinical study that has shown the ...
Anumana’s innovative AI algorithms recognized for their transformative potential in cardiology - the first of which is now commercially available “At Anumana, we are committed to developing ...
Southlake, TX, Nov. 13, 2024 (GLOBE NEWSWIRE) -- Heart Test Laboratories, Inc. (HSCS) d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback